BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19605405)

  • 21. Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells.
    Lo R; Burgoon L; Macpherson L; Ahmed S; Matthews J
    Biochim Biophys Acta; 2010; 1799(5-6):469-79. PubMed ID: 20079471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SnoN oncoprotein enhances estrogen receptor-α transcriptional activity.
    Band AM; Laiho M
    Cell Signal; 2012 Apr; 24(4):922-30. PubMed ID: 22227247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells.
    Boerner JL; Gibson MA; Fox EM; Posner ED; Parsons SJ; Silva CM; Shupnik MA
    Mol Endocrinol; 2005 Nov; 19(11):2660-70. PubMed ID: 15976008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anacardic acid inhibits estrogen receptor alpha-DNA binding and reduces target gene transcription and breast cancer cell proliferation.
    Schultz DJ; Wickramasinghe NS; Ivanova MM; Isaacs SM; Dougherty SM; Imbert-Fernandez Y; Cunningham AR; Chen C; Klinge CM
    Mol Cancer Ther; 2010 Mar; 9(3):594-605. PubMed ID: 20197399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells.
    Chakravarty D; Nair SS; Santhamma B; Nair BC; Wang L; Bandyopadhyay A; Agyin JK; Brann D; Sun LZ; Yeh IT; Lee FY; Tekmal RR; Kumar R; Vadlamudi RK
    Cancer Res; 2010 May; 70(10):4092-101. PubMed ID: 20460518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth.
    Wu K; Katiyar S; Witkiewicz A; Li A; McCue P; Song LN; Tian L; Jin M; Pestell RG
    Cancer Res; 2009 Apr; 69(8):3347-55. PubMed ID: 19351840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A hypersensitive estrogen receptor alpha mutation that alters dynamic protein interactions.
    Herynk MH; Hopp T; Cui Y; Niu A; Corona-Rodriguez A; Fuqua SA
    Breast Cancer Res Treat; 2010 Jul; 122(2):381-93. PubMed ID: 19842032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters.
    Matthews J; Wihlén B; Thomsen J; Gustafsson JA
    Mol Cell Biol; 2005 Jul; 25(13):5317-28. PubMed ID: 15964790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PELP1 is a reader of histone H3 methylation that facilitates oestrogen receptor-alpha target gene activation by regulating lysine demethylase 1 specificity.
    Nair SS; Nair BC; Cortez V; Chakravarty D; Metzger E; Schüle R; Brann DW; Tekmal RR; Vadlamudi RK
    EMBO Rep; 2010 Jun; 11(6):438-44. PubMed ID: 20448663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gli1 promotes cell survival and is predictive of a poor outcome in ERalpha-negative breast cancer.
    Xu L; Kwon YJ; Frolova N; Steg AD; Yuan K; Johnson MR; Grizzle WE; Desmond RA; Frost AR
    Breast Cancer Res Treat; 2010 Aug; 123(1):59-71. PubMed ID: 19902354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors.
    Vadlamudi RK; Balasenthil S; Broaddus RR; Gustafsson JA; Kumar R
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6130-8. PubMed ID: 15579769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Augmentation of estrogen receptor-mediated transcription by steroid and xenobiotic receptor.
    Rokutanda N; Iwasaki T; Odawara H; Nagaoka R; Miyazaki W; Takeshita A; Koibuchi Y; Horiguchi J; Shimokawa N; Iino Y; Morishita Y; Koibuchi N
    Endocrine; 2008 Jun; 33(3):305-16. PubMed ID: 19011999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.
    Laganière J; Deblois G; Lefebvre C; Bataille AR; Robert F; Giguère V
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11651-6. PubMed ID: 16087863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.
    Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J
    J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-alpha transactivation functions.
    Mishra SK; Mazumdar A; Vadlamudi RK; Li F; Wang RA; Yu W; Jordan VC; Santen RJ; Kumar R
    J Biol Chem; 2003 May; 278(21):19209-19. PubMed ID: 12639951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.
    Keeton EK; Brown M
    Mol Endocrinol; 2005 Jun; 19(6):1543-54. PubMed ID: 15802375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell fate determination factor DACH1 inhibits c-Jun-induced contact-independent growth.
    Wu K; Liu M; Li A; Donninger H; Rao M; Jiao X; Lisanti MP; Cvekl A; Birrer M; Pestell RG
    Mol Biol Cell; 2007 Mar; 18(3):755-67. PubMed ID: 17182846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
    Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
    Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptor 9 agonist inhibits ERalpha-mediated transactivation by activating NF-kappaB in breast cancer cell lines.
    Qiu J; Wang X; Guo X; Zhao C; Wu X; Zhang Y
    Oncol Rep; 2009 Oct; 22(4):935-41. PubMed ID: 19724876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional interactions between the estrogen receptor coactivator PELP1/MNAR and retinoblastoma protein.
    Balasenthil S; Vadlamudi RK
    J Biol Chem; 2003 Jun; 278(24):22119-27. PubMed ID: 12682072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.